PUBLISHED DATE : Nov 2019 | Pages : 268
Fill out your details & get your free sample
Digital Diabetes Management Market Size, Share, Trends, Analysis Report by Products (SMBG Meters, CGM Devices, Insulin Pumps, Digital Insulin Pens), Applications, and Software), Distribution Channels (Retail and Online Stores), End-Users (Individual, Hospitals, Specialty Diabetics Clinics, And Others), and Geography (North America, APAC, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Market Share & Forecast, 2019–2024
268 Pages
86 Tables
120 Charts
5 Regions
19 Countries
52 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (REVENUE) | USD 13 BILLION (2024) |
| CAGR | 18% (2019-2024) |
| Base Year | 2018 |
| Forecast Year | 2019-2024 |
| Market Segments | Products (SMBG Meters, CGM Devices, Insulin Pumps, Digital Insulin Pens), Applications, and Software), Distribution Channels (Retail and Online Stores), End-Users (Individual, Hospitals, Specialty Diabetics Clinics, And Others) |
| Geographic Analysis | North America, APAC, Europe, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, Argentina, Australia, Brazil, China, France, Germany, India, Iran, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, Turkey, and UK |
The digital diabetes management market size will reach USD 13 billion by 2024, growing at a CAGR of 18% during 2019-2025. The market has witnessed significant growth in sales volume due to the growing prevalence of diabetes and the increasing awareness of self-management of the disease. The increased demand from developing regions, the introduction of innovative smart diabetes management devices, and increased marketing activities via online stores contribute to the growth of the market worldwide.
The market has been witnessing a broad range of technological innovations and improvements in recent years. As the demand for digitally advanced blood glucose monitoring devices is growing significantly, vendors are focusing on developing innovative devices, incorporating new technological platforms, and improving existing ones to enhance overall patient care. Besides, vendors are also offering a wide range of innovative BGM devices with improved features such as inbuilt alert systems, wireless connectivity, data storage, compatibility with Android and iOS platforms, and messaging options to evaluate the patient’s blood glucose levels regularly. Hence, the introduction of advanced digital devices has enabled both patients and healthcare professionals to monitor blood glucose levels in real-time, thereby enhancing the management of diabetes.
The digital diabetes management market is highly influenced by the increasing adoption of smartphones, wearable medical devices, and the availability of several mHealth applications for blood glucose tracking. mHealth applications and data integration software platforms help in storing blood glucose data of the patient and transmitting the same to healthcare professionals for clinical decision making. Therefore, the increasing usage of mobile applications and data management platforms contributes to the growing demand for smart devices for effective and accurate diabetic management.
This research report includes detailed segmentation by
The digital diabetes management devices segment is growing at a faster rate due to the growing adoption of several digitally advanced diabetic care devices, including digital blood glucose meters, Continuous Glucose Monitoring (CGM) devices, insulin pumps, and digital insulin pens. Among all these devices, CGM devices are contributing to the largest share in 2018. The wide availability of technologically advanced blood glucose monitoring devices and the rapid expansion of telehealthcare facilities contribute to the digital diabetes management market share.
The growing prevalence of diabetes, mainly in the growing geriatric population, is the key factor driving the growth of the applications and software segment. Further, technological advancements are a crucial factor in the development of the segment. The encouraging sale of smartphones, coupled with growing focus on home healthcare and remote patient monitoring, has led to several mHealth applications for tracking several health activities such as physical activities, blood glucose levels, blood pressure, heart rate, among others.
Retail stores are considered an indispensable distribution channel for digital diabetes monitoring devices. They offer easy access to a broad customer base and involve personalized attention to each consumer’s needs. A major exciting trend observed in this distribution system is that they are increasingly getting integrated with online platforms with retail chains either having their standalone online portals or participating through marketplaces through e-commerce companies.
Online stores have played a pivotal role in dispensing information and bringing radical changes in the consumption pattern and the shopping behavior of consumers. The rise of standalone web portals for retailers and the emergence of exclusive online marketplaces for home care and self-testing products such as digital BGM devices have recently gained attention in the market. For instance, BGM devices and accessories are readily available through online e-commerce portals such as Amazon, Flipkart, Snapdeal, and Paytm. Besides, manufacturers are also offering BGM devices through direct B2C online channels.
The rapidly increasing diabetic population due to unhealthy lifestyle patterns, excess alcohol consumption, low diet, and the lack of physical activities worldwide are majorly contributing to the growing demand for several digital diabetes devices. Also, the healthcare industry has witnessed a paradigm shift in the last decade with an increasing preference toward self-monitoring of blood glucose levels over hospital-based testing.
Healthcare professionals in hospitals and clinics use professional devices for quick and accurate measurement of blood glucose levels. The hospital segment is growing at a healthy rate and is likely to grow steadily during the forecast period. The adoption of POC tests, which is increasing at a significant rate for evaluating blood glucose levels, is a major factor for digital diabetes management market growth. The availability of skilled healthcare professionals with knowledge and expertise in assessing blood glucose levels and aiding in diabetes management attracts more patients to hospitals and clinics than other healthcare providers.
The growing diabetic patient population, high preference for self-monitoring of blood glucose levels, and the advent of highly advanced and innovative blood glucose management devices are the primary factors for the high share in North America. Also, the growing geriatric population with an increased risk of increasing blood glucose levels is another key factor driving the growth of the region.
Europe is the second-largest market. Germany, France, Spain, the UK, and Italy are the major revenue contributors in Europe. The growth is mainly due to the highly sophisticated healthcare infrastructure, the increasing patient population with high awareness levels regarding the availability of advanced treatment options for diabetic care.
APAC is the third-largest market. It has the largest population density and the highest proportion of people with diabetes. India and China population have around 195 million people with diabetes. Japan, China, South Korea, India, and Australia are the major revenue contributors from the region. China, South Korea, and India hold significant shares and are expected to witness the significant growth rate due to advancements in healthcare infrastructure, the rise in healthcare expenditure, and favorable public and private initiatives for an increase in the healthcare access.
Brazil, Mexico, and Argentina are the major revenue contributors to the digital diabetes management market shares in Latin America. Turkey, Saudi Arabia, Iran, and South Africa are the major revenue contributors in MEA. The lack of awareness and the availability of various advanced treatment options for diabetic management have led to lower uptake in MEA than the US, Europe, Latin America, and APAC.
The global digital diabetes management market is highly competitive and dynamic, characterized by the presence of many international, regional, and local vendors offering a diverse range of technologically advanced devices, including CGM devices, test strips, digital insulin pens, insulin pumps sensors, lancets, and lancing devices for enhancing/improving the overall patient care. Approximately more than 400 vendors are offering such a wide array of products worldwide. Many global, regional, and local players manufacture and promote a diverse range of devices for the effective management of diabetes. The market is subject to rapid technological changes and significantly affected by new product launched and other strategies of industry participants Abbott, Ascensia Diabetes Care, B. Braun Melsungen, Dexcom, F. Hoffmann-La Roche, LifeScan, Medtronic, and Insulet are the major players.
Segmentation by Products
By Distribution Channel Type
By End-users
By Geography
Frequently Asked Questions
What is the digital diabetes management market size in 2019?
The digital diabetes management market size will reach USD 13 billion in 2024, growing at a CAGR of 18% during 2019-2024.
The digital diabetes management devices segment is growing at a faster rate due to the growing adoption of several digitally advanced diabetic care devices, including digital blood glucose meters, Continuous Glucose Monitoring (CGM) devices, insulin pumps, and digital insulin pens
Europe is the second-largest market. Germany, France, Spain, the UK, and Italy are the major revenue contributors in Europe. The growth is mainly due to the highly sophisticated healthcare infrastructure, the increasing patient population with high awareness levels regarding the availability of advanced treatment options for diabetic care
The leading vendors are Abbott, Ascensia Diabetes Care, B. Braun Melsungen, Dexcom, F. Hoffmann-La Roche, LifeScan, Medtronic, and Insulet.
The global digital diabetes management market is growing at a CAGR of over 18% during the forecast period 2018–2024.
The following factors are likely to contribute to the growth of the market during the forecast period:
Base Year: 2018
Forecast Year: 2019–2024
The study considers the present scenario of the digital diabetes management market and its market dynamics for the period 2018−2024. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply aspects of the market. The report profiles and examines leading companies and other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Market Segmentation by Products
Market Segmentation by Distribution Channel Type
Market Segmentation by End-users
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.2 Market Segmentation by Distribution Channels
4.4.3 Market Segmentation By End-user Type
4.4.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Diabetes: An Overview
7.1.1 Background
7.1.2 Digital Diabetes Management
7.1.3 Global Digital Diabetes Management: Market Snapshot
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Growing Prevalence of Diabetes
8.1.2 Growing Technological Advancements in Digital Diabetes Management
8.1.3 Increasing Availability of Mobile Applications
8.1.4 New Product Approvals/Launches
8.2 Market Growth Restraints
8.2.1 High Cost of Digital Diabetes Management Devices
8.2.2 Presence of Large Pool of Undiagnosed Population
8.2.3 Threat from Conventional Diabetes Management Devices
8.3 Market Opportunities & Trends
8.3.1 Emergence of Closed Loop/Hybrid Insulin Pumps
8.3.2 Growing Demand for Smart Insulin Pens
8.3.3 Rising Popularity of Connected/Smart Diabetes Management Devices
8.3.4 Promising Investigational Digital Diabetes Management Devices
9 Global Digital Diabetes Management Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 Digital Diabetes Management Market by Product Type
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
11 Digital Diabetes Management Devices
11.1 Market Overview
11.1.1 Market Size & Forecast
11.2 Segmentation by Product Type
11.2.1 Market Snapshot & Growth Engine
11.3 CGM Devices
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 Insulin Pumps
11.4.1 Market Overview
11.4.2 Market Size & Forecast
11.5 Digital Blood Glucose Meters
11.5.1 Market Overview
11.5.2 Market Size & Forecast
11.6 Digital Insulin Pens
11.6.1 Market Overview
11.6.2 Market Size & Forecast
12 Digital Diabetes Management Apps & Software
12.1 Market Overview
12.1.1 Market Size & Forecast
13 Digital Diabetes Management Market by Distribution Channels
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Offline Retail Channels
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Online Channels
13.4.1 Market Overview
13.4.2 Market Size & Forecast
14 Digital Diabetes Management Market by End-Users
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Individuals
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Hospitals & Specialty Diabetes Clinics
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Other End-users
14.5.1 Market Overview
14.5.2 Market Size & Forecast
15 Digital Diabetes Management Market by Geography
15.1 Market Snapshot & Growth Engine
15.2 Overview
16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 US: Market Size & Forecast
16.3.2 Canada: Market Size & Forecast
17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Germany: Market Size & Forecast
17.3.2 France: Market Size & Forecast
17.3.3 Spain: Market Size & Forecast
17.3.4 UK: Market Size & Forecast
17.3.5 Italy: Market Size & Forecast
18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 China: Market Size & Forecast
18.3.2 Japan: Market Size & Forecast
18.3.3 South Korea: Market Size & Forecast
18.3.4 India: Market Size & Forecast
18.3.5 Australia: Market Size & Forecast
19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Brazil: Market Size & Forecast
19.3.2 Mexico: Market Size & Forecast
19.3.3 Argentina: Market Size & Forecast
20 Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Turkey: Market Size & Forecast
20.3.2 Saudi Arabia: Market Size & Forecast
20.3.3 Iran: Market Size & Forecast
20.3.4 South Africa: Market Size & Forecast
21 Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Digital Blood Glucose Meters
21.2.2 CGM Devices
21.2.3 Digital Insulin Pens
21.2.4 Insulin Pumps
22 Key Vendors
22.1 Ascensia Diabetes Care
22.1.1 Business Overview
22.1.2 Major Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 Abbott
22.2.1 Business Overview
22.2.2 Abbott in Global Digital Diabetes Management Market
22.2.3 Major Product Offerings
22.2.4 Key Strategies
22.2.5 Key Strengths
22.2.6 Key Opportunities
22.3 B. Braun Melsungen
22.3.1 Business Overview
22.3.2 B. Braun Melsungen in Global Digital Diabetes Management Market
22.3.3 Major Product Offerings
22.3.4 Key Strategies
22.3.5 Key Strengths
22.3.6 Key Opportunities
22.4 Dexcom
22.4.1 Business Overview
22.4.2 Dexcom in Global Digital Diabetes Management Market
22.4.3 Major Product Offerings
22.4.4 Key Strategies
22.4.5 Key Strengths
22.4.6 Key Opportunities
22.5 F. Hoffmann-La Roche
22.5.1 Business Overview
22.5.2 F. Hoffmann-La Roche in The Global Digital Diabetes Management Market
22.5.3 Major Product Offerings
22.5.4 Key Strategies
22.5.5 Key Strengths
22.5.6 Key Opportunities
22.6 LifeScan
22.6.1 Business Overview
22.6.2 LifeScan in Global Digital Diabetes Management Market
22.6.3 Major Product Offerings
22.6.4 Key Strategies
22.6.5 Key Strengths
22.6.6 Key Opportunities
22.7 Medtronic
22.7.1 Business Overview
22.7.2 Medtronic in Global Digital Diabetes Management Market
22.7.3 Major Product Offerings
22.7.4 Key Strategies
22.7.5 Key Strengths
22.7.6 Key opportunities
22.8 Insulet
22.8.1 Business Overview
22.8.2 Insulet in Global Digital Diabetes Management Market
22.8.3 Major Product Offerings
22.8.4 Key Strategies
22.8.5 Key Strengths
22.8.6 Key Opportunities
23 Other Prominent Vendors
23.1 77 ELEKTRONIKA
23.1.1 Business Overview
23.1.2 Major Product Offerings
23.2 A. Menarini Diagnostics
23.2.1 Business Overview
23.2.2 Major Product Offerings
23.3 ACON Laboratories
23.3.1 Business Overview
23.3.2 Major Product Offerings
23.4 Agamatrix
23.4.1 Business Overview
23.4.2 Major Product Offerings
23.5 Alliance International
23.5.1 Business Overview
23.5.2 Major Product Offerings
23.6 Andon Health (Tianjin Jiu'an Medical Electronics)
23.6.1 Business Overview
23.6.2 Major Product Offerings
23.7 Animas
23.7.1 Business Overview
23.7.2 Major Product Offerings
23.8 ApexBio
23.8.1 Business Overview
23.8.2 Major Product Offerings
23.9 Arkray
23.9.1 Business Overview
23.9.2 Major Product Offerings
23.1 Beurer
23.10.1 Business Overview
23.10.2 Major Product Offerings
23.11 Biocorp
23.11.1 Business Overview
23.11.2 Major Product Offerings
23.12 Bionime
23.12.1 Business Overview
23.12.2 Major Product Offerings
23.13 Bioptik
23.13.1 Business Overview
23.13.2 Major Product Offerings
23.14 BioTelemetry
23.14.1 Business Overview
23.14.2 Major Product Offerings
23.15 Biotest Medical
23.15.1 Business Overview
23.15.2 Major Product Offerings
23.16 BTNX
23.16.1 Business Overview
23.16.2 Major Product Offerings
23.17 Care Innovations
23.17.1 Business Overview
23.17.2 Major Product Offerings
23.18 Companion Medical
23.18.1 Business Overview
23.18.2 Major Product Offerings
23.19 DarioHealth
23.19.1 Business Overview
23.19.2 Major Product Offerings
23.20 Diabnext
23.20.1 Business Overview
23.20.2 Major Product Offerings
23.21 DIAMESCO
23.21.1 Business Overview
23.21.2 Major Product Offerings
23.22 Digital Medics
23.22.1 Business Overview
23.22.2 Major Product Offerings
23.23 Emperra
23.23.1 Business Overview
23.23.2 Major Product Offerings
23.24 GlucoMe
23.24.1 Business Overview
23.24.2 Major Product Offerings
23.25 Integrity Applications
23.25.1 Business Overview
23.25.2 Major Product Offerings
23.26 Jiangsu Delfu medical device
23.26.1 Business Overview
23.26.2 Major Product Offerings
23.27 Medisana
23.27.1 Business Overview
23.27.2 Major Product Offerings
23.28 Medtrum Technologies
23.28.1 Business Overview
23.28.2 Major Product Offerings
23.29 Nova Biomedical
23.29.1 Business Overview
23.29.2 Major Product Offerings
23.30 Novo Nordisk
23.30.1 Business Overview
23.30.2 Major Product Offerings
23.31 Omnis Health
23.31.1 Business Overview
23.31.2 Major Product Offerings
23.32 One Drop
23.32.1 Business Overview
23.32.2 Major Product Offerings
23.33 Philosys
23.33.1 Business Overview
23.33.2 Major Product Offerings
23.34 Prodigy Diabetes Care
23.34.1 Business Overview
23.34.2 Major Product Offerings
23.35 Sanofi
23.35.1 Business Overview
23.35.2 Major Product Offerings
23.36 Senseonics Holdings
23.36.1 Business Overview
23.36.2 Major Product Offerings
23.37 SOOIL Developments
23.37.1 Business Overview
23.37.2 Major Product Offerings
23.38 Taidoc Technology
23.38.1 Business Overview
23.38.2 Major Product Offerings
23.39 Terumo
23.39.1 Business Overview
23.39.2 Major Product Offerings
23.40 Trividia Health
23.40.1 Business Overview
23.40.2 Major Product Offerings
23.41 Rossmax International
23.41.1 Business Overview
23.41.2 Major Product Offerings
23.42 Tandem Diabetes Care
23.42.1 Business Overview
23.42.2 Major Product Offerings
23.43 Patients Pending
23.43.1 Business Overview
23.43.2 Major Product Offerings
23.44 Ypsomed
23.44.1 Business Overview
23.44.2 Major Product Offerings
24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations
24.3 Quantitative Summary
24.3.1 By Product
24.3.2 By Distribution Channel
24.3.3 By End-user
24.3.4 By Geography
24.3.5 Digital Diabetes Management Devices
25 Appendix
25.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Digital Diabetes Management Market
Exhibit 2 Market Size Calculation Approach 2018
Exhibit 3 Blood Glucose Level Range & Associated Risk Factors
Exhibit 4 Growing Prevalence of Diabetes
Exhibit 5 Global Diabetes Prevalence 2017−2045 (%)
Exhibit 6 Global Prevalence of Diabetes in Females by Age Group 2017 (%)
Exhibit 7 Global Prevalence of Diabetes in Males by Age Group 2017 (%)
Exhibit 8 Growing Technological Advancements in Digital Diabetes Management
Exhibit 9 Increasing Availability of Mobile Applications
Exhibit 10 New Product Approvals/Launches
Exhibit 11 High Cost of Digital Diabetes Management Devices
Exhibit 12 Global Diabetes-related Expenditure by Regions 2017 ($ billion)
Exhibit 13 Presence of Large Pool of Undiagnosed Population
Exhibit 14 Global Undiagnosed Diabetes Population (20–79 Years by Regions 2017 (%))
Exhibit 15 Threat from Conventional Diabetes Management Devices
Exhibit 16 Challenges to Adoption of Diabetes Management Devices vs. Conventional Devices
Exhibit 17 Emergence of Closed Loop/Hybrid Insulin Pumps
Exhibit 18 Growing Demand for Smart Insulin Pens
Exhibit 19 Rising Popularity of Connected/Smart Diabetes Management Devices
Exhibit 20 Promising Investigational Digital Diabetes Management Devices
Exhibit 21 Importance of Blood Glucose Monitoring in Diabetes Management
Exhibit 22 Global Digital Diabetes Management Market 2018−2024 ($ million)
Exhibit 23 Global Market by Geography
Exhibit 24 Global Market by Product Type
Exhibit 25 Global Market by Distribution Channels
Exhibit 26 Global Market by End-users
Exhibit 27 Five Forces Analysis 2018
Exhibit 28 Incremental Growth by Product Type 2018−2024
Exhibit 29 Global Digital Diabetes Management Market by Product Type
Exhibit 30 Global Market by Product Type: Incremental Growth
Exhibit 31 Global Market by Product Type: Absolute Growth
Exhibit 32 Global Market by Product Type 2018 & 2024 (%)
Exhibit 33 Global Market by Product Type 2018−2024 ($ million)
Exhibit 34 Digital Diabetes Management Devices: Incremental Growth
Exhibit 35 Digital Diabetes Management Devices: Absolute Growth
Exhibit 36 Digital Diabetes Management Devices 2018 & 2024 (%)
Exhibit 37 Digital Diabetes Management Devices 2018−2024 ($ million)
Exhibit 38 Digital Diabetes Management Devices 2018−2024 (%)
Exhibit 39 Global Digital Diabetes Management Devices Market 2018−2024 ($ million)
Exhibit 40 Incremental Growth by Product Type 2018−2024
Exhibit 41 Global CGM Devices Market 2018−2024 ($ million)
Exhibit 42 Global Insulin Pumps Market 2018−2024 ($ million)
Exhibit 43 Global Digital Diabetes Meters Market 2018−2024 ($ million)
Exhibit 44 Global Digital Insulin Pens Market 2018−2024 ($ million)
Exhibit 45 Global Digital Diabetes Apps & Software Market 2018−2024 ($ million)
Exhibit 46 Incremental Growth by Distribution Channels
Exhibit 47 Global Digital Diabetes Management Market by Distribution Channels 2018 & 2024 (%)
Exhibit 48 Global Market by Distribution Channels 2018−2024 ($ million)
Exhibit 49 Digital Market by Distribution Channels 2018− 2024 (%)
Exhibit 50 Global Market by Distribution Channels
Exhibit 51 Global Market by Distribution Channels: Absolute Growth
Exhibit 52 Global Offline Digital Diabetes Management Market 2018−2024 ($ million)
Exhibit 53 Global Online Digital Diabetes Management Market 2018−2024 ($ million)
Exhibit 54 Incremental Growth by End-users Type
Exhibit 55 Global Digital Diabetes Management Market by End-users 2018−2024 ($ million)
Exhibit 56 Global Market by End-users 2018−2024 (%)
Exhibit 57 Global Market by End-users
Exhibit 58 Global Individual Digital Diabetes Management Market 2018−2024 ($ million)
Exhibit 59 Global Hospitals & Specialty Diabetes Clinics Market 2018−2024 ($ million)
Exhibit 60 Global Other Digital Diabetes Management Market 2018−2024 ($ million)
Exhibit 61 Incremental Growth by Geography 2018−2024
Exhibit 62 Global Digital Diabetes Management Market by Geography
Exhibit 63 Global Market by Geography 2018−2024 ($ million)
Exhibit 64 Diabetes Prevalence Rate among Females in North America by Age Group 2017 (%)
Exhibit 65 Diabetes Prevalence Rate among Males in North America by Age Group 2017 (%)
Exhibit 66 North America Diabetes Statistics by Country 2017 (%)
Exhibit 67 Market in North America 2018−2024 ($ million)
Exhibit 68 Incremental Growth in North America 2018−2024
Exhibit 69 Market in US 2018−2024 ($ million)
Exhibit 70 Market in Canada 2018−2024 ($ million)
Exhibit 71 Diabetes Prevalence Rate among Females in Europe by Age Group 2017 (%)
Exhibit 72 Diabetes Prevalence Rate Among Males in Europe by Age Group 2017 (%)
Exhibit 73 Market in Europe 2018–2024 ($ million)
Exhibit 74 Incremental Growth in Europe 2018−2024
Exhibit 75 Market in Germany 2018–2024 ($ million)
Exhibit 76 Market in France 2018–2024 ($ million)
Exhibit 77 Market in Spain 2018–2024 ($ million)
Exhibit 78 Market in UK 2018–2024 ($ million)
Exhibit 79 Market in Italy 2018–2024 ($ million)
Exhibit 80 Market in APAC 2018−2024 ($ million)
Exhibit 81 Incremental Growth in APAC 2018−2024
Exhibit 82 Market in China 2018−2024 ($ million)
Exhibit 83 Market in Japan 2018−2024 ($ million)
Exhibit 84 Market in South Korea 2018−2024 ($ million)
Exhibit 85 Market in India 2018−2024 ($ million)
Exhibit 86 Prevalence of Self-Reported Diabetes in People Aged 18 and Over, by Age and Sex, 2017–2018 (%)
Exhibit 87 Market in Australia 2018−2024 ($ million)
Exhibit 88 Diabetes Prevalence Rate among Females in Latin America by Age Group 2017 (%)
Exhibit 89 Diabetes Prevalence Rate Among Females in Latin America by Age Group 2017 (%)
Exhibit 90 Market in LATAM 2018−2024 ($ million)
Exhibit 91 Incremental Growth in Latin America 2018−2024
Exhibit 92 Market in Brazil 2018−2024 ($ million)
Exhibit 93 Market in Mexico 2018−2024 ($ million)
Exhibit 94 Number of Diabetes Deaths in Different Age Groups by Gender 2016
Exhibit 95 Market in Argentina 2018−2024 ($ million)
Exhibit 96 Diabetes Prevalence Rate in Females in MEA by Age Group 2017 (%)
Exhibit 97 Diabetes Prevalence Rate in Males in MEA by Age Group 2017 (%)
Exhibit 98 Market in MEA 2018−2024 ($ million)
Exhibit 99 Incremental Growth in MEA 2018−2024
Exhibit 100 Market in Turkey 2018−2024 ($ million)
Exhibit 101 Market in Saudi Arabia 2018−2024 ($ million)
Exhibit 102 Market in Iran 2018−2024 ($ million)
Exhibit 103 Market in South Africa 2018−2024 ($ million)
Exhibit 104 Global CGM Devices Market: Key Vendors Market Share
Exhibit 105 Global Insulin Pumps Market: Key Vendors Market Share
Exhibit 106 Abbott: R&D Expenditure 2016−2018 ($ million)
Exhibit 107 Abbott: Sales Breakdown by Segments 2017−2018 ($ million)
Exhibit 108 Abbott Sales Breakdown by Geography 2018 (%)
Exhibit 109 B. Braun Melsungen R&D Expenditure 2016−2018 ($ million)
Exhibit 110 B. Braun Melsungen Revenue by Division 2017−2018 ($ million)
Exhibit 111 B. Braun Melsungen Sales by Region 2018 (%)
Exhibit 112 Dexcom: R&D Expenditure 2016−2018 ($ million)
Exhibit 113 Dexcom: Revenue by Geography 2018 (%)
Exhibit 114 F. Hoffmann-La Roche R&D Expenditure 2016−2018 ($ billion)
Exhibit 115 F. Hoffmann-La Roche Revenue by Business Segments 2017−2018 ($ billion)
Exhibit 116 F. Hoffmann-La Roche Revenue by Geography 2018 (%)
Exhibit 117 Medtronic: Revenue by Business Segments 2017−2018 ($ million)
Exhibit 118 Medtronic: Revenue Breakdown by Geography FY2018 (%)
Exhibit 119 Insulet: R&D Expenditure 2016−2018 ($ million)
Exhibit 120 Insulet: Revenue by Divisions 2017−2018 ($ million)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2018
Table 3 Standard Range of Blood Sugar Levels
Table 4 Few Latest-generation Blood Glucose Monitoring Devices Available in Market
Table 5 Common Features in mHealth Diabetes Management Applications in Addition to BGM
Table 6 Key Mobile Applications and Data Integration Platforms for Diabetes Management
Table 7 Recent Product Approvals & Launches in Global Digital Diabetes Management Market
Table 8 Leading Countries with Highest Undiagnosed Diabetes Population 2017
Table 9 Emerging Next-generation Closed-loop Insulin Delivery Systems
Table 10 Connected/Smart Diabetes Management Devices Available in the Market
Table 11 Global Digital Diabetes Management Devices Market: Pipeline Devices
Table 12 Commercially Available CGM Devices by Significant Market Players
Table 13 Significant Players Offering Insulin Pumps
Table 14 Few Significant Players Offering Advanced BGM Devices
Table 15 Significant Players Offering Insulin Pens
Table 16 Several Diabetes Management Platforms & Software Available in the Market
Table 17 Countries with Highest Diabetic Population in Europe 2017
Table 18 Countries with Highest Diabetes Population in APAC 2017
Table 19 Countries with Highest Diabetes Population in Latin America 2017
Table 20 Leading Countries with Diabetes Population in MEA 2017
Table 21 Global Digital Blood Glucose Meters Market: Top Vendors Ranking
Table 22 Global CGM Devices Market: Top Vendors Ranking
Table 23 Global Insulin Pumps Market: Top Vendors Ranking
Table 24 Ascensia Diabetes Care: Key Product Offerings
Table 25 Abbott: Key Product Offerings
Table 26 B. Braun Melsungen’s Therapy Fields & Applications
Table 27 B. Braun Melsungen: Key Product Offerings
Table 28 Dexcom: Key Product Offerings
Table 29 F. Hoffmann-La Roche: Key Product Offerings
Table 30 LifeScan: Key Product Offerings
Table 31 Medtronic: Key Product Offerings
Table 32 Insulet: Key Product Offerings
Table 33 77 ELEKTRONIKA: Key Product Offerings
Table 34 A. Menarini Diagnostics: Key Product Offerings
Table 35 ACON Laboratories: Key Product Offerings
Table 36 AgaMatrix: Key Product Offerings
Table 37 Alliance International: Key Product Offerings
Table 38 ANDON HEALTH (TIANJIN JIU'AN MEDICAL ELECTRONICS): Key Product Offerings
Table 39 Animas: Key Product Offerings
Table 40 ApexBio: Key Product Offerings
Table 41 ARKRAY: Key Product Offerings
Table 42 BEURER: Key Product Offerings
Table 43 BIOCORP: Key Product Offerings
Table 44 Bionime: Key Product Offerings
Table 45 Bioptik: Key Product Offerings
Table 46 BioTelemetry: Key Product Offerings
Table 47 BIOTEST MEDICAL: Key Product Offerings
Table 48 BTNX: Key Product Offerings
Table 49 Care Innovations: Key Product Offerings
Table 50 Companion Medical: Key Product Offerings
Table 51 DarioHealth: Key Product Offerings
Table 52 Diabnext: Key Product Offerings
Table 53 DIAMESCO: Key Product Offerings
Table 54 Digital Medics: Key Product Offerings
Table 55 Emperra: Key Product Offerings
Table 56 GlucoMe: Key Product Offerings
Table 57 Integrity Applications: Key Product Offerings
Table 58 Jiangsu Delfu medical device: Key Product Offerings
Table 59 Medisana: Key Product Offerings
Table 60 Medtrum Technologies: Key Product Offerings
Table 61 Nova Biomedical: Key Product Offerings
Table 62 Novo Nordisk: Key Product Offerings
Table 63 Omnis Health: Key Product Offerings
Table 64 One Drop: Key Product Offerings
Table 65 Philosys: Key Product Offerings
Table 66 Prodigy Diabetes Care: Key Product Offerings
Table 67 Sanofi: Key Product Offerings
Table 68 Senseonics Holdings: Key Product Offerings
Table 69 SOOIL Developments: Key Product Offerings
Table 70 Taidoc Technology: Key Product Offerings
Table 71 Terumo: Key Product Offerings
Table 72 Trividia Health: Key Product Offerings
Table 73 Rossmax International: Key Product Offerings
Table 74 Tandem Diabetes Care: Key Product Offerings
Table 75 Patients Pending: Key Product Offerings
Table 76 Ypsomed: Key Product Offerings
Table 77 Global Digital Diabetes Management Market by Products ($ million)
Table 78 Global Market by Products (%)
Table 79 Global Digital Diabetes Management Market by Distribution Channels ($ million)
Table 80 Global Market by Distribution Channels (%)
Table 81 Global Digital Diabetes Management Market by End-users ($ million)
Table 82 Global Market by End-users (%)
Table 83 Global Digital Diabetes Management Market by Geography ($ million)
Table 84 Global Digital Diabetes Management Devices Market by Geography (%)
Table 85 Global Digital Diabetes Management Devices Market ($ million)
Table 86 Global Digital Diabetes Management Devices Market (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
